Rozerem
Product Images NDC 21695-183

2 FDA label images from Rebel Distributors Corp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Rozerem (NDC 21695-183). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (3740dcc6 9ee8 4187 9112 632050043240 01)

Chemical Structure (3740dcc6 9ee8 4187 9112 632050043240 01)
Chemical structure of the active ingredient in Rozerem, showing a molecular diagram with labeled atoms and bonds illustrating its chemical composition.*
FDA Label Image

Rozerem 8mg (3740dcc6 9ee8 4187 9112 632050043240 02)

Rozerem 8mg (3740dcc6 9ee8 4187 9112 632050043240 02)
Rozerem 8mg tablets packaging label showing 30 tablets per container. The label states each tablet contains 8mg of Ramelteon and displays the NDC 21695-183-30. It is distributed by Physician Partner in Thousand Oaks, CA, with storage instructions at controlled room temperature 15°-30°C. The label includes a note that tablets are round, pale orange-yellow, with "TAK" and "RAN" printed on each.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.